Page 1,314«..1020..1,3131,3141,3151,316..1,3201,330..»

New funds allocated to fund trial for Parkinson disease – TheCannabisRadar

Posted: Published on October 24th, 2019

We all are aware of how the Arthritis Association is requesting the government to fund CBD research because several patients suffering from the illness have discovered relief. Likewise in a move that might be a big breakthrough in the field of medicine, patients suffering from Parkinsons disease are all set to become a part of a clinical trial. The research will aim at finding out how CBD can be effective and safe to treat symptoms like hallucinations and delusions Continue reading →

Posted in Parkinson's Treatment | Comments Off on New funds allocated to fund trial for Parkinson disease – TheCannabisRadar

Google searches show millions of people want to learn about CBD here are 3 things you should know about it – MarketWatch

Posted: Published on October 24th, 2019

Public curiosity about CBD is soaring and a new study has the numbers to show it. Continue reading →

Posted in Parkinson's Treatment | Comments Off on Google searches show millions of people want to learn about CBD here are 3 things you should know about it – MarketWatch

AZTherapies Strengthens Neuroinflammation-Targeted Pipeline Through Acquisition of Smith Therapeutics – BioSpace

Posted: Published on October 24th, 2019

BOSTON, Oct. 24, 2019 (GLOBE NEWSWIRE) -- AZTherapies, Inc., a biopharmaceutical company developing therapeutics to extend brain health, today announced the acquisition of Smith Therapeutics, a private biopharmaceutical company with a shared goal of targeting neuroinflammation to treat neurodegenerative disease. Continue reading →

Posted in Parkinson's Treatment | Comments Off on AZTherapies Strengthens Neuroinflammation-Targeted Pipeline Through Acquisition of Smith Therapeutics – BioSpace

Sage Therapeutics Looks A Buy At Current Price – Seeking Alpha

Posted: Published on October 24th, 2019

Thesis In my view, Sage Therapeutics (SAGE) shares are undervalued, but are unlikely to be so for much longer. The company has already brought Zulresso to market and is likely to gain approval for SAGE-217 in the near future. Continue reading →

Posted in Parkinson's Treatment | Comments Off on Sage Therapeutics Looks A Buy At Current Price – Seeking Alpha

Media Advisory – Canadian Cardiovascular Congress gathers leading heart experts in Montreal to discuss latest research innovations – Canada NewsWire

Posted: Published on October 24th, 2019

MONTRAL, Oct. Continue reading →

Posted in Cardiac Rhythm Abnormalities | Comments Off on Media Advisory – Canadian Cardiovascular Congress gathers leading heart experts in Montreal to discuss latest research innovations – Canada NewsWire

Research Improves Understanding of Mechanism of Atrial Fibrillation | – Diagnostic and Interventional Cardiology

Posted: Published on October 24th, 2019

October 22, 2019 Atrial fibrillation is the most common heart arrhythmia in humans. This condition increases the risk of heart failure, stroke, dementia and death, and current treatments have suboptimal efficacy and carry side effects Continue reading →

Posted in Interventional Cardiology | Comments Off on Research Improves Understanding of Mechanism of Atrial Fibrillation | – Diagnostic and Interventional Cardiology

Interventional Cardiology Devices Market Research Report (2019-2025): Type, Analysis and Global Forecast | Cordis, Boston Scientific, GE Healthcare -…

Posted: Published on October 24th, 2019

The Global Interventional Cardiology Devices report 2019 to 2025 spreads the market foundation and its development prospects on the up and coming years furthermore briefs about Interventional Cardiology Devices item life expectancy, contrasting it into the administrations and items from crosswise over Interventional Cardiology Devices organizations that had been popularized. This report studies in the universal market utilizing generation, income, utilization, deals, import and fare, worldwide Interventional Cardiology Devices piece of the overall industry, and development rate in the figure stage 2019-2025. The market is bifurcated relying upon item type, Interventional Cardiology Devices applications, end-clients, key players, and areas. Continue reading →

Posted in Interventional Cardiology | Comments Off on Interventional Cardiology Devices Market Research Report (2019-2025): Type, Analysis and Global Forecast | Cordis, Boston Scientific, GE Healthcare -…

Teleflex Announces Third Quarter 2019 Earnings Conference Call Information – GlobeNewswire

Posted: Published on October 24th, 2019

WAYNE, Pa., Oct. 17, 2019 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) announced today that financial results for the third quarter 2019 will be released before market open on Thursday, October 31, 2019. An investor conference call will be held at 8:00 a.m Continue reading →

Posted in Interventional Cardiology | Comments Off on Teleflex Announces Third Quarter 2019 Earnings Conference Call Information – GlobeNewswire

Cardiac Surgery Instruments Market is Expected to Tread a Steady Growth Trajectory by Clocking a CAGR of 5.9% from 2017 to 2022 – Health News Office

Posted: Published on October 24th, 2019

The BLOOD PLASMA DERIVATIVES market research report added by Report Ocean, is an in-depth analysis of the latest trends, market size, status, upcoming technologies, industry drivers, challenges, regulatory policies, with key company profiles and strategies of players. The research study provides market introduction, BLOOD PLASMA DERIVATIVES market definition, regional market scope, sales and revenue by region, manufacturing cost analysis, Industrial Chain, market effect factors analysis, BLOOD PLASMA DERIVATIVES market size forecast, 100+ market data, Tables, Pie Chart, Graphs and Figures, and many more for business intelligence Continue reading →

Posted in ALS Treatment | Comments Off on Cardiac Surgery Instruments Market is Expected to Tread a Steady Growth Trajectory by Clocking a CAGR of 5.9% from 2017 to 2022 – Health News Office

CAC Scoring Can Identify High-Risk Adults Who Could Benefit From Anticoagulation Therapy – Consultant360

Posted: Published on October 24th, 2019

Coronary artery calcium (CAC) scoring can accurately identify high-risk adults who may benefit from low-dose rivaroxaban for the primary prevention of atherosclerotic cardiovascular disease (ASCVD), according to a new analysis of the Multi-Ethnic Study of Atherosclerosis (MESA) study. To reach this conclusion, the researchers modeled expected outcomes of low-dose rivaroxaban in 5196 participants in the MESA study who were not already receiving antiplatelet or anticoagulant therapy Continue reading →

Posted in Myocardial Infarction | Comments Off on CAC Scoring Can Identify High-Risk Adults Who Could Benefit From Anticoagulation Therapy – Consultant360

Page 1,314«..1020..1,3131,3141,3151,316..1,3201,330..»